Report Feature
The future of the global organoid and spheroid market looks promising with opportunities in developmental biology, personalized medicine, regenerative medicine, disease pathology study, and drug toxicity & efficacy testing applications. The global organoid and spheroid market is expected to grow with a CAGR of 22%-24% from 2020 to 2025. The major drivers for this market are rising drug development activity and increasing demand for tissue engineering and organ transplantation.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global organoid and spheroid market report, please download the report brochure.
In this market, spheroids is the largest type segment of organoid and spheroid, whereas development of regenerative medicine is the largest application. Growth in various segments of the organoid and spheroid market are given below:
The study includes trends and forecast for the global organoid and spheroid market by type, application, end use, and region as follows:
By Type [Value ($ Million) shipment analysis for 2014 – 2025]:
-
Organoids
-
By Product Type:
- Neural Organoids
- Hepatic Organoids
- Intestinal Organoids
- Other Organoids
-
By Method:
- General Submerged Method for Organoid Culture
- Crypt Organoid Culture Techniques
- Air Liquid Interface (ALI) Method for Organoid Culture
- Clonal Organoids from Lgr5+ Cells
- Brain and Retina Organoid Formation Protocol
-
By Source:
- Primary Tissues
- Stem Cells
-
By Product Type:
-
Spheroids
-
By Product Type:
- Multicellular Tumor Spheroids (MCTS)
- Neurospheres
- Mammospheres
- Hepatospheres
- Embryoid Bodies
-
By Method:
- Micropatterned Plates
- Low Cell Attachment Plates
- Hanging Drop Method
- Others
-
By Source:
- Cell Line
- Primary Cell
- iPSCs (Induced Pluripotent Stem Cells) Derived Cells
-
By Product Type:
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
- Developmental Biology
- Personalized Medicine
- Regenerative Medicine
- Disease Pathology Studies
- Drug Toxicity & Efficacy Testing
By End Use [Value ($ Million) shipment analysis for 2014 – 2025]:
- Biotechnology and Pharmaceutical Industries
- Academic & Research Institutes
- Hospitals and Diagnostic Centers
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
-
North America
- United States
- Canada
- Mexico
-
Europe
- United Kingdom
- Germany
- France
-
Asia Pacific
- China
- India
- Japan
-
The Rest of the World
-
Brazil
-
Some of the organoid and spheroid companies profiled in this report include 3D Biomatrix, 3D Biotek, AMS Biotechnology, ATCC, Cellesce, Corning, Greiner Bio-One, Hubrecht Organoid Technology (HUB), PerkinElmer; and Kuraray.
Lucintel forecasts that spheroids will remain the largest type segment over the forecast period due to its increasing usage in drug discovery and cancer research.
Within this market, biotechnology and pharmaceutical industries will remain the largest end user segment over the forecast period due to increasing usage of organoids and spheroids in pre-clinical drug discovery by pharma entities.
North America will remain the largest region over the forecast period due to rising implementation of organoid based research models of organoids and spheroids in the biotechnology sector of the U.S. and Canada and presence of efficient manufacturers in the region.
|
Features of the Global Organoid and Spheroid Market |
|
|
This report answers following key questions |
|
Q.1 What are some of the most promising potential, high-growth opportunities for the global organoid and spheroid market by type (organoids [product type {neural organoids, hepatic organoids, intestinal organoids, and other organoids}, method {general submerged method for organoid culture, crypt organoid culture techniques, ALI method for organoid culture, clonal organoids from Lgr5+ cells, and brain & retina organoid formation protocol}, and source {primary tissues and stem cells}] and spheroids [product type {MCTS, neurospheres, mammospheres, hepatospheres, and embryoid bodies), method {micropatterned plates, low cell attachment plates, hanging drop method, and others}, and source {cell line, primary cell, and iPSCs derived cells}]), application (developmental biology, personalized medicine, regenerative medicine, disease pathology studies, and drug toxicity & efficacy testing), end use (biotechnology & pharmaceutical industries, academic & research institutes, and hospitals & diagnostic centers), and region (North America, Europe, Asia Pacific, and Rest of the World)? Q.2 Which segments will grow at a faster pace and why? Q.3 Which region will grow at a faster pace and why? Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global organoid and spheroid market? Q.5 What are the business risks and threats to the global organoid and spheroid market? Q.6 What are the emerging trends in this organoid and spheroid market and the reasons behind them? Q.7 What are some changing demands of customers in this organoid and spheroid market? Q.8 What are the new developments in this organoid and spheroid market? Which companies are leading these developments? Q.9 Who are the major players in this organoid and spheroid market? What strategic initiatives are being implemented by key players for business growth? Q.10 What are some of the competitive products and processes in this organoid and spheroid market, and how big of a threat do they pose for loss of market share via material or product substitution? Q.11 What M&A activities did take place in the last five years in the global organoid and spheroid market? |
Report Scope
| Key Features | Description |
| Base Year for Estimation | 2019 |
|
Trend Period (Actual Estimates) |
2014-2019 |
| Forecast Period | 2020-2025 |
| Pages | More than 150 |
| Market Representation / Units | Revenue in US $ Million |
| Report Coverage | Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling |
| Market Segments | Type (Organoids and Spheroids), Application (Developmental Biology, Personalized Medicine, Regenerative Medicine, Disease Pathology Studies, and Drug Toxicity & Efficacy Testing), and End Use (Biotechnology & Pharmaceutical Industries, Academic & Research Institutes, and Hospitals & Diagnostic Centers) |
Regional Scope |
North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil) |
| Customization | 10% Customization without Any Additional Cost |
Table of Contents
1. Executive Summary
7.2 Emerging Trends in the Global Organoid and Spheroid Market
4.1 Global Organoid and Spheroid Market by Region
4.2.1 Market by Type: Organoids and Spheroids
4.2.2 Market by Application: Developmental Biology, Personalized Medicine, Regenerative Medicine, Disease Pathology Studies, and Drug Toxicity & Efficacy Testing
4.2.3 Market by End Use: Biotechnology and Pharmaceutical Industries, Academic & Research Institutes, and Hospitals and Diagnostic Centers
4.2.4 The United States Organoid and Spheroid Market
4.2.5 The Canadian Organoid and Spheroid Market
4.2.6 The Mexican Organoid and Spheroid Market
4.3.1 Market by Type: Organoids and Spheroids
4.3.2 Market by Application: Developmental Biology, Personalized Medicine, Regenerative Medicine, Disease Pathology Studies, and Drug Toxicity & Efficacy Testing
4.3.3 Market by End Use: Biotechnology and Pharmaceutical Industries, Academic & Research Institutes, and Hospitals and Diagnostic Centers
4.3.4 The Organoid and Spheroid Market of United Kingdom
4.3.5 The German Organoid and Spheroid Market
4.3.6 The French Organoid and Spheroid Market
4.4.1 Market by Type: Organoids and Spheroids
4.4.2 Market by Application: Developmental Biology, Personalized Medicine, Regenerative Medicine, Disease Pathology Studies, and Drug Toxicity & Efficacy Testing
4.4.3 Market by End Use: Biotechnology and Pharmaceutical Industries, Academic & Research Institutes, and Hospitals and Diagnostic Centers
4.4.4 The Chinese Organoid and Spheroid Market
4.4.5 The Indian Organoid and Spheroid Market
4.4.6 The Japanese Organoid and Spheroid Market
4.5.1 Market by Type: Organoids and Spheroids
4.5.2 Market by Application: Developmental Biology, Personalized Medicine, Regenerative Medicine, Disease Pathology Studies, and Drug Toxicity & Efficacy Testing
4.5.3 Market by End Use: Biotechnology and Pharmaceutical Industries, Academic & Research Institutes, and Hospitals and Diagnostic Centers
4.5.4 Brazilian Organoid and Spheroid Market
7.1.1 Growth Opportunities for the Global Organoid and Spheroid Market by Type
7.1.2 Growth Opportunities for the Global Organoid and Spheroid Market by Application
7.1.3 Growth Opportunities for the Global Organoid and Spheroid Market by End Use
7.1.4 Growth Opportunities for the Global Organoid and Spheroid Market by Region
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
